Clinical Cancer Research AACR Conference on Cancer Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, X.
Right arrow Articles by Lippman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, X.
Right arrow Articles by Lippman, M.
Clinical Cancer Research Vol. 6, 3424-3429, September 2000
© 2000 American Association for Cancer Research


Advances in Brief

KAI1 Protein Is Down-Regulated during the Progression of Human Breast Cancer1

Xiaohong Yang, Lisa Wei, Careen Tang, Rebecca Slack, Elizabeth Montgomery2 and Marc Lippman3

Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007

The KAI1 gene was identified as a metastasis suppressor gene for human prostate cancer. Recently, we showed that KAI1 mRNA levels were higher in an immortal, normal-like breast epithelial cell line and nonmetastatic breast cancer cell lines but lower substantially in highly metastatic breast cancer cell lines. In this study, we examined KAI1 protein expression in breast cancer cell lines by Western blot and immunohistochemical study. KAI1 protein levels paralleled KAI1 mRNA levels and were inversely correlated with the metastatic potential of breast cancer cells. Furthermore, we examined KAI1 protein expression immunohistochemically in specimens from 81 patients with breast cancer and then correlated the findings with the clinical and histopathological parameters of the patients. High levels of KAI1 protein expression were found in normal breast tissues and noninvasive breast cancer (ductal carcinoma in situ). In contrast, KAI1 expression was reduced in most of the infiltrating breast tumors. We found that, in general, more malignant tumors demonstrated significantly lower KAI1 expression (P = 0.004). Additionally, among 29 specimens demonstrating multiple stages of malignancy within a single specimen, 23 demonstrated significant differences in KAI1 expression between benign breast tissue, ductal carcinoma in situ, and invasive carcinoma. The higher the incidence for malignancy within a given specimen, the lower the KAI1 expression (P < 0.001). These data suggest that in advanced breast cancer, KAI1 expression is down-regulated. Therefore, KAI1 may be a potentially useful indicator of human breast cancer progression.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
H. Huang, J. Groth, K. Sossey-Alaoui, L. Hawthorn, S. Beall, and J. Geradts
Aberrant Expression of Novel and Previously Described Cell Membrane Markers in Human Breast Cancer Cell Lines and Tumors
Clin. Cancer Res., June 15, 2005; 11(12): 4357 - 4364.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Zhou, L. Liu, M. Reddivari, and X. A. Zhang
The Palmitoylation of Metastasis Suppressor KAI1/CD82 Is Important for Its Motility- and Invasiveness-Inhibitory Activity
Cancer Res., October 15, 2004; 64(20): 7455 - 7463.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. H. Lee, Y.-W. Seo, S. R. Park, Y. J. Kim, and K. K. Kim
Expression of a Splice Variant of KAI1, a Tumor Metastasis Suppressor Gene, Influences Tumor Invasion and Progression
Cancer Res., November 1, 2003; 63(21): 7247 - 7255.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F.-S. Liu, J.-T. Dong, J.-T. Chen, Y.-T. Hsieh, E. S.-C. Ho, M.-J. Hung, C.-H. Lu, and L.-C. Chiou
KAI1 Metastasis Suppressor Protein Is Down-Regulated during the Progression of Human Endometrial Cancer
Clin. Cancer Res., April 1, 2003; 9(4): 1393 - 1398.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. S. Wilson, H. Roberts, R. Leek, A. L. Harris, and J. Geradts
Differential Gene Expression Patterns in HER2/neu-Positive and -Negative Breast Cancer Cell Lines and Tissues
Am. J. Pathol., October 1, 2002; 161(4): 1171 - 1185.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Yang, L. L. Wei, C. Tang, R. Slack, S. Mueller, and M. E. Lippman
Overexpression of KAI1 Suppresses in Vitro Invasiveness and in Vivo Metastasis in Breast Cancer Cells
Cancer Res., July 1, 2001; 61(13): 5284 - 5288.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.